Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

37.56
-0.4150-1.09%
Volume:3.17M
Turnover:119.21M
Market Cap:75.80B
PE:19.09
High:37.99
Open:37.96
Low:37.31
Close:37.97
Loading ...
Mar 25, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 21, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 19, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 19, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 19, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 18, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 12, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 12, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 11, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 08, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 05, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 01, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 22, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 22, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 21, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 21, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 20, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]